Gainers
- Tilray Brands (NASDAQ:TLRY) shares rose 12.9% to $7.87 during Thursday's after-market session. Trading volume for this security closed at 16.5 million, accounting for 76.5% of its average full-day volume over the last 100 days. The company's market cap stands at $3.7 billion.
- Poseida Therapeutics (NASDAQ:PSTX) stock moved upwards by 10.33% to $5.55. The market value of their outstanding shares is at $347.1 million.
- Sundial Growers (NASDAQ:SNDL) stock rose 8.99% to $0.81. This security traded at a volume of 41.4 million shares come close, making up 55.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.6 billion.
- Sonendo (NYSE:SONX) stock rose 8.24% to $4.99. The market value of their outstanding shares is at $131.4 million. As per the press release, Q4 earnings came out yesterday.
- Prelude Therapeutics (NASDAQ:PRLD) stock moved upwards by 7.06% to $7.88. The company's market cap stands at $375.3 million.
- Orchard Therapeutics (NASDAQ:ORTX) stock moved upwards by 6.83% to $0.83. The market value of their outstanding shares is at $104.1 million.
Losers
- MEI Pharma (NASDAQ:MEIP) stock fell 43.6% to $1.02 during Thursday's after-market session. MEI Pharma's trading volume hit 2.2 million shares by close, accounting for 235.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $135.6 million.
- Owlet (NYSE:OWLT) shares fell 7.08% to $4.07. The market value of their outstanding shares is at $459.2 million.
- Co-Diagnostics (NASDAQ:CODX) stock decreased by 7.07% to $6.05. Trading volume for this security closed at 58.7K, accounting for 9.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $176.4 million. As per the press release, Q4 earnings came out today.
- SAB Biotherapeutics (NASDAQ:SABS) stock decreased by 6.87% to $1.9. The company's market cap stands at $82.6 million.
- Cara Therapeutics (NASDAQ:CARA) shares declined by 6.66% to $11.5. The market value of their outstanding shares is at $615.4 million.
- Rezolute (NASDAQ:RZLT) stock declined by 6.01% to $3.76. The market value of their outstanding shares is at $58.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
